Repligen Aktie
141,20
EUR
-5,85
EUR
-3,98
%
165,82
USD
-3,23
USD
-1,91
%
Werbung
Repligen Aktie Analyse
| 28.08.19 | Repligen Outperform | First Analysis Securities | |
| 22.07.19 | Repligen Buy | H.C. Wainwright & Co. | |
| 02.10.17 | Repligen Overweight | First Analysis Securities | |
| 29.10.09 | Repligen buy | Merriman Curhan Ford & Co | |
| 30.06.09 | Repligen buy | Merriman Curhan Ford & Co | |
| 13.06.08 | Repligen market outperform | Rodman & Renshaw, LLC | |
| 20.05.08 | Repligen | Global Biotech Investing | |
| 11.09.07 | Repligen market outperform | Rodman & Renshaw | |
|
Werbung
|
|||
| 12.04.07 | Repligen market outperform | Rodman & Renshaw | |
| 29.12.05 | Repligen overweight | Lehman Brothers | |
| 27.05.05 | Repligen market outperform | Rodman & Renshaw | |
Werbung
Werbung